المؤلفون: Garbis, SD, Roumeliotis, TI, Tyritzis, SI, Zorpas, KM, Pavlakis, K, Constantinides, CA

المصدر: Analytical chemistry. 83(3):708-718

مصطلحات موضوعية: Medicin och hälsovetenskap

URL الوصول: http://kipublications.ki.se/Default.aspx?queryparsed=id:121922466

المؤلفون: Berger, C, Crepin, V, Roumeliotis, TI, Wright, JC, Carson, D, Pevsner-Fischer, M, Furniss, RCD, Dougan, G, Bachash, M, Yu, L, Clements, A, Collins, JW, Elinav, E, Larrouy-maumus, G, Choudhary, JS, Frankel, GM

المساهمون: Medical Research Council (MRC), Wellcome Trust

المصدر: 752.e6

مصطلحات موضوعية: Male, Proteomics, INHIBITION, type III secretion system effectors, Srebp2, METABOLISM, 0601 Biochemistry and Cell Biology, digestive system, Cell Line, ENERGY, Endocrinology & Metabolism, cholesterol biogenesis, Feces, Mice, Adenosine Triphosphate, INFLAMMATION, INFECTION, Animals, Humans, Metabolomics, reprogram metabolism, NITRIC-OXIDE SYNTHASE, MODULATION, Intestinal Mucosa, ADAPTATION, SPECIFICITY, GENE-EXPRESSION, Mice, Inbred C3H, Science & Technology, hypoxia, Epithelial Cells, Cell Biology, creatine biogenesis, Immunity, Innate, Mitochondria, Mice, Inbred C57BL, Cholesterol, 1101 Medical Biochemistry and Metabolomics, Citrobacter rodentium, lipids (amino acids, peptides, and proteins), Abca1, Female, Life Sciences & Biomedicine, cholesterol efflux

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______1032::252fdc0917439ffc4316a1dbc5c883b2
http://hdl.handle.net/10044/1/50675

المؤلفون: Cirillo L; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Young R; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Veerapathiran S; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Roberti A; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Martin M; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Abubacar A; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Perosa C; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Coates C; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Muhammad R; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Roumeliotis TI; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Choudhary JS; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK., Alfieri C; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK. claudio.alfieri@icr.ac.uk., Pines J; The Institute of Cancer Research Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK. jon.pines@icr.ac.uk.

المصدر: The EMBO journal [EMBO J] 2024 Aug 14. Date of Electronic Publication: 2024 Aug 14.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8208664 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2075 (Electronic) Linking ISSN: 02614189 NLM ISO Abbreviation: EMBO J Subsets: MEDLINE

المؤلفون: Mannion J; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Gifford V; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Bellenie B; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Fernando W; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Ramos Garcia L; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Wilson R; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., John SW; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Udainiya S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Patin EC; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Tiu C; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Smith A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Goicoechea M; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Craxton A; MRC Toxicology Unit, University of Cambridge, Gleeson Building, Cambridge CB2 1QR, UK., Moraes de Vasconcelos N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Guppy N; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Cheung KJ; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Cundy NJ; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Pierrat O; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Brennan A; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Roumeliotis TI; Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK., Benstead-Hume G; Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK., Alexander J; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Muirhead G; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Layzell S; Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK., Lyu W; Department of Immunology and Microbiology, LEO Foundation Skin Immunology Research Center, University of Copenhagen, Copenhagen, Denmark., Roulstone V; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Allen M; Biological Services Unit, The Institute of Cancer Research, London SW3 6JB, UK., Baldock H; Biological Services Unit, The Institute of Cancer Research, London SW3 6JB, UK., Legrand A; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Gabel F; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Serrano-Aparicio N; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Starling C; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Guo H; Department of Microbiology and Immunology, LSU Health Shreveport, Shreveport, LA, USA., Upton J; Department of Biological Sciences, Auburn University, Auburn, AL, USA., Gyrd-Hansen M; Department of Immunology and Microbiology, LEO Foundation Skin Immunology Research Center, University of Copenhagen, Copenhagen, Denmark., MacFarlane M; MRC Toxicology Unit, University of Cambridge, Gleeson Building, Cambridge CB2 1QR, UK., Seddon B; Institute of Immunity and Transplantation, University College London, London NW3 2PP, UK., Raynaud F; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Roxanis I; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Harrington K; Division of Radiotherapy and Imaging, The Institute of Cancer Research, London SW3 6JB, UK., Haider S; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK., Choudhary JS; Functional Proteomics Group, The Institute of Cancer Research, London SW3 6JB, UK., Hoelder S; Centre for Cancer Drug Discovery at the Institute of Cancer Research, London SM2 5NG, UK., Tenev T; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK. Electronic address: tencho.tenev@icr.ac.uk., Meier P; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, Fulham Road, London SW3 6JB, UK. Electronic address: pmeier@icr.ac.uk.

المصدر: Immunity [Immunity] 2024 Jul 09; Vol. 57 (7), pp. 1514-1532.e15. Date of Electronic Publication: 2024 May 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE

مواضيع طبية MeSH: Receptor-Interacting Protein Serine-Threonine Kinases*/metabolism , Proteolysis*/drug effects , Signal Transduction*/drug effects , Immunogenic Cell Death*/drug effects, Humans ; Animals ; Mice ; Cell Line, Tumor ; Necroptosis/drug effects ; Necroptosis/immunology ; Neoplasms/immunology ; Neoplasms/drug therapy ; Mice, Inbred C57BL ; Antineoplastic Agents/pharmacology ; Immunotherapy/methods

المؤلفون: Badja C; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK. Electronic address: cb998@cam.ac.uk., Momen S; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK., Koh GCC; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK., Boushaki S; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK., Roumeliotis TI; Functional Proteomics Group, Institute of Cancer Research, Chester Betty Labs, 237 Fulham Road, London SW3 6JB, UK., Kozik Z; Functional Proteomics Group, Institute of Cancer Research, Chester Betty Labs, 237 Fulham Road, London SW3 6JB, UK., Jones I; Dynamical Cell Systems Laboratory, Division of Cancer Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK., Bousgouni V; Dynamical Cell Systems Laboratory, Division of Cancer Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK., Dias JML; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK., Krokidis MG; Institute of Nanoscience and Nanotechnology, N.C.S.R. 'Demokritos', Agia Paraskevi Attikis, 15310 Athens, Greece; Bioinformatics and Human Electrophysiology Laboratory, Department of Informatics, Ionian University, 49100 Corfu, Greece., Young J; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK., Chen H; Wellcome Sanger Institute, Hinxton CB10 1RQ, UK; Department of Rheumatology and Immunology, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China., Yang M; Medical Research Council Cancer Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XZ, UK; CECAD Research Center, Faculty of Medicine, University Hospital Cologne, Joseph-Stelzmann-Str. 26, 50931 Cologne, Germany., Docquier F; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK., Memari Y; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK., Valcarcel-Zimenez L; Medical Research Council Cancer Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XZ, UK; CECAD Research Center, Faculty of Medicine, University Hospital Cologne, Joseph-Stelzmann-Str. 26, 50931 Cologne, Germany., Gupta K; Medical Research Council Cancer Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XZ, UK., Kong LR; Medical Research Council Cancer Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XZ, UK; NUS Centre for Cancer Research, N2CR, Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117599, Singapore; Cancer Science Institute of Singapore, Singapore 117599, Singapore., Fawcett H; Genome Damage and Stability Centre, University of Sussex, Brighton, UK., Robert F; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK., Zhao S; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK., Degasperi A; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK., Kumar Y; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK., Davies H; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK., Harris R; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK., Frezza C; Medical Research Council Cancer Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge CB2 0XZ, UK; CECAD Research Center, Faculty of Medicine, University Hospital Cologne, Joseph-Stelzmann-Str. 26, 50931 Cologne, Germany., Chatgilialoglu C; Istituto per la Sintesi Organica e la Fotoreattività, Consiglio Nazionale delle Ricerche, Via P. Gobetti 101, 40129 Bologna, Italy; Center for Advanced Technologies, Adam Mickiewicz University, 61-614 Poznan, Poland., Sarkany R; National Xeroderma Pigmentosum Service, St John's Institute of Dermatology, Guy's and St Thomas' Foundation Trust, London SE1 7EH, UK., Lehmann A; Genome Damage and Stability Centre, University of Sussex, Brighton, UK., Bakal C; Dynamical Cell Systems Laboratory, Division of Cancer Biology, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, UK., Choudhary J; Functional Proteomics Group, Institute of Cancer Research, Chester Betty Labs, 237 Fulham Road, London SW3 6JB, UK., Fassihi H; National Xeroderma Pigmentosum Service, St John's Institute of Dermatology, Guy's and St Thomas' Foundation Trust, London SE1 7EH, UK., Nik-Zainal S; Department of Medical Genetics, Box 238, Level 6, Addenbrooke's Treatment Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0QQ, UK; Early Cancer Institute, Department of Oncology, Box 197, Hutchison Research Centre, Cambridge Biomedical Research Campus, Cambridge CB2 0XZ, UK. Electronic address: sn206@cam.ac.uk.

المصدر: Cell reports [Cell Rep] 2024 Jun 25; Vol. 43 (6), pp. 114243. Date of Electronic Publication: 2024 May 27.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE

مواضيع طبية MeSH: Xeroderma Pigmentosum*/pathology , Xeroderma Pigmentosum*/metabolism , Xeroderma Pigmentosum*/genetics , Induced Pluripotent Stem Cells*/metabolism, Humans ; Neurons/metabolism ; Neurons/pathology ; Oxidative Stress ; Endoplasmic Reticulum Stress ; Proteasome Endopeptidase Complex/metabolism ; Cell Differentiation ; DNA Damage ; Models, Biological ; Multiomics

المؤلفون: Lau R; Clinical Pharmacology and Adaptive Therapy Group, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London SM2 5PT, United Kingdom., Yu L; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London SW3 6JB, United Kingdom., Roumeliotis TI; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London SW3 6JB, United Kingdom., Stewart A; Clinical Pharmacology and Adaptive Therapy Group, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London SM2 5PT, United Kingdom., Pickard L; Clinical Pharmacology and Adaptive Therapy Group, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London SM2 5PT, United Kingdom., Choudhary JS; Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London SW3 6JB, United Kingdom., Banerji U; Clinical Pharmacology and Adaptive Therapy Group, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London SM2 5PT, United Kingdom.

المصدر: Journal of proteome research [J Proteome Res] 2024 Jun 07; Vol. 23 (6), pp. 2160-2168. Date of Electronic Publication: 2024 May 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101128775 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1535-3907 (Electronic) Linking ISSN: 15353893 NLM ISO Abbreviation: J Proteome Res Subsets: MEDLINE

مواضيع طبية MeSH: Cancer-Associated Fibroblasts*/metabolism , Cancer-Associated Fibroblasts*/drug effects , Cancer-Associated Fibroblasts*/pathology , Secretome*/metabolism, Humans ; Cell Line, Tumor ; Antineoplastic Agents/pharmacology ; Drug Resistance, Neoplasm ; Proto-Oncogene Proteins p21(ras)/genetics ; Proto-Oncogene Proteins p21(ras)/metabolism ; Neoplasms/drug therapy ; Neoplasms/metabolism ; Neoplasms/pathology ; Mass Spectrometry ; Pancreatic Neoplasms/metabolism ; Pancreatic Neoplasms/drug therapy ; Pancreatic Neoplasms/pathology ; Proteomics/methods ; Lung Neoplasms/metabolism ; Lung Neoplasms/drug therapy ; Lung Neoplasms/pathology ; Lung Neoplasms/genetics

المؤلفون: Klein P; Division of Biosciences, Institute of Structural and Molecular Biology, University College London, Darwin Building, Gower Street, London, WC1E 6XA, UK.; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Petrić Howe M; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK., Harley J; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK.; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK., Crook H; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Esteban Serna S; Division of Biosciences, Institute of Structural and Molecular Biology, University College London, Darwin Building, Gower Street, London, WC1E 6XA, UK., Roumeliotis TI; Functional Proteomics team, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK., Choudhary JS; Functional Proteomics team, The Institute of Cancer Research, 237 Fulham Road, London, SW3 6JB, UK., Chakrabarti AM; RNA Networks Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK., Luisier R; Idiap Research Institute, Martigny, 1920, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, 1015, Switzerland., Patani R; Human Stem Cells and Neurodegeneration Laboratory, The Francis Crick Institute, 1 Midland Road, London, NW1 1AT, UK. rickie.patani@ucl.ac.uk.; Department of Neuromuscular Diseases, Queen Square Institute of Neurology, University College London, London, WC1N 3BG, UK. rickie.patani@ucl.ac.uk., Ramos A; Division of Biosciences, Institute of Structural and Molecular Biology, University College London, Darwin Building, Gower Street, London, WC1E 6XA, UK. a.ramos@ucl.ac.uk.

المصدر: Nature communications [Nat Commun] 2024 Jun 06; Vol. 15 (1), pp. 4819. Date of Electronic Publication: 2024 Jun 06.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: RNA-Binding Proteins*/metabolism , RNA-Binding Proteins*/genetics , Microtubules*/metabolism , Neurons*/metabolism , Neurons*/cytology , Cell Differentiation*/genetics , RNA, Messenger*/metabolism , RNA, Messenger*/genetics, Humans ; Methylation ; Neurogenesis/genetics ; Adenosine/metabolism ; Adenosine/analogs & derivatives ; Gene Expression Regulation, Developmental

المؤلفون: Mazza T; Department of Life Sciences, Imperial College London, SW7 2AZ, London, UK.; Rutherford Appleton Laboratory, Research Complex at Harwell, Didcot, Oxfordshire, OX11 0FA, UK.; Department DiBEST (Biologia, Ecologia, Scienze Della Terra) Unit of Biochemistry and Molecular Biotechnology, University of Calabria, 87036, Arcavacata di Rende, Italy., Roumeliotis TI; Functional Proteomics group, Chester Beatty Laboratories, The Institute of Cancer Research, London, SW3 6JB, UK., Garitta E; Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, E1 2A, London, UK., Drew D; Department of Biochemistry and Biophysics, Stockholm University, 10691, Stockholm, Sweden., Rashid ST; Department of Metabolism, Digestion & Reproduction, Imperial College London, W12 0NN, London, UK., Indiveri C; Department DiBEST (Biologia, Ecologia, Scienze Della Terra) Unit of Biochemistry and Molecular Biotechnology, University of Calabria, 87036, Arcavacata di Rende, Italy.; CNR Institute of Biomembranes, Bioenergetics and Molecular Biotechnology (IBIOM), 70126, Bari, Italy., Choudhary JS; Functional Proteomics group, Chester Beatty Laboratories, The Institute of Cancer Research, London, SW3 6JB, UK., Linton KJ; Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, E1 2A, London, UK., Beis K; Department of Life Sciences, Imperial College London, SW7 2AZ, London, UK. kbeis@imperial.ac.uk.; Rutherford Appleton Laboratory, Research Complex at Harwell, Didcot, Oxfordshire, OX11 0FA, UK. kbeis@imperial.ac.uk.

المصدر: Nature communications [Nat Commun] 2024 Mar 04; Vol. 15 (1), pp. 1983. Date of Electronic Publication: 2024 Mar 04.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

مواضيع طبية MeSH: Probenecid*/pharmacology , Biological Assay*, Humans ; Animals ; Rats ; Phosphorylation ; Binding Sites ; Biological Transport ; Membrane Transport Proteins ; Multidrug Resistance-Associated Protein 2

المؤلفون: Baxter JS; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Brough R; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Krastev DB; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Song F; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Sridhar S; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Gulati A; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Alexander J; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Roumeliotis TI; Functional Proteomics Laboratory, The Institute of Cancer Research, London, UK., Kozik Z; Functional Proteomics Laboratory, The Institute of Cancer Research, London, UK., Choudhary JS; Functional Proteomics Laboratory, The Institute of Cancer Research, London, UK., Haider S; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Pettitt SJ; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Tutt ANJ; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK., Lord CJ; The CRUK Gene Function Laboratory, The Institute of Cancer Research, London, UK.; Breast Cancer Now Toby Robins Breast Cancer Research Centre, The Institute of Cancer Research, London, UK.

المصدر: Molecular oncology [Mol Oncol] 2024 Feb; Vol. 18 (2), pp. 369-385. Date of Electronic Publication: 2023 Oct 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101308230 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-0261 (Electronic) Linking ISSN: 15747891 NLM ISO Abbreviation: Mol Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Cell Cycle Proteins*/genetics , Cell Cycle Proteins*/metabolism , Neoplasms*/genetics, Humans ; F-Box-WD Repeat-Containing Protein 7/genetics ; Cell Line, Tumor ; Ubiquitination ; RNA Interference ; Protein Domains ; Ubiquitin-Protein Ligases/metabolism ; Protein Serine-Threonine Kinases/metabolism ; Chromosomal Proteins, Non-Histone/genetics

المؤلفون: Bouguenina H; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Scarpino A; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., O'Hanlon JA; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Warne J; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Wang HZ; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Wah Hak LC; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Sadok A; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.; Monte Rosa Therapeutics AG, Aeschenvorstadt 36, 4051, Basel, Switzerland., McAndrew PC; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Stubbs M; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Pierrat OA; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Hahner T; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Cabry MP; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Le Bihan YV; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Mitsopoulos C; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Sialana FJ; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.; Functional Proteomics Group, The Institute of Cancer Research, Chester Beatty Laboratories, London, SW3 6JB, UK., Roumeliotis TI; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.; Functional Proteomics Group, The Institute of Cancer Research, Chester Beatty Laboratories, London, SW3 6JB, UK., Burke R; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., van Montfort RLM; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Choudhari J; Functional Proteomics Group, The Institute of Cancer Research, Chester Beatty Laboratories, London, SW3 6JB, UK., Chopra R; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.; Apple Tree Partners, The Gridiron Building, Suite 6.05, 1 St Pancras Square, London, N1 C 4AG, UK., Caldwell JJ; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK., Collins I; Centre for Cancer Drug Discovery, Institute of Cancer Research, 15 Cotswold Road, Sutton, London, SM2 5NG, UK.

المصدر: Chembiochem : a European journal of chemical biology [Chembiochem] 2023 Dec 01; Vol. 24 (23), pp. e202300351. Date of Electronic Publication: 2023 Oct 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 100937360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-7633 (Electronic) Linking ISSN: 14394227 NLM ISO Abbreviation: Chembiochem Subsets: MEDLINE

مواضيع طبية MeSH: Ubiquitin-Protein Ligases*/metabolism, Proteolysis